Pancreatic Cancer Research

ResearcherUniversity of Maryland, BaltimoreActive in the last 2 years

Christina Ferrer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0006-8651-9154; OpenAlex author ID A5004849325; NIH RePORTER profile ID 11756641. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
3
Labs led
1
Collaborators
3
Papers, trials and grants by year

2021: 1 grant · 2022: none · 2023: 1 grant · 2024: 1 grant · 2025: none · 2026: 2 papers

Papers 2

  1. GSTT1 promotes stemness and FGFR inhibitor sensitivity in pancreatic cancer through regulation of CD133 (PROM1). Last author DOI 10.1016/j.canlet.2026.218733↗
  2. KRAS on Empty: Lipid Oxidation Blockade Reveals a Metabolic Achilles' Heel in Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-25-1877↗

Grants 3

  1. Role of Gstt1 in metastatic maintenance and self-renewal in PDA R00CA252600↗
  2. Lustgarten Foundation-AACR Career Development Award: Christina M. Ferrer AWARD lustgarten:2023-christina-m-ferrer-phd-lustgarten-foundation-aacr-career-develo
  3. Role of Gstt1 in metastatic maintenance and self-renewal in PDA K99CA252600↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deborah de la Caridad Delgado Herrera · 2 shared papers, 2026 · strength 0.93
  2. Elana Judith Fertig · 1 shared paper, 2026 · strength 0.30
  3. Emily L. Lasse Opsahl · 1 shared paper, 2026 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.